BiotechTube

S5G4T-1 + S5G4T-2

Phase 3Completed
0 watching 0 views this week📈 Rising
69
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Papulopustular Rosacea

Conditions

Papulopustular Rosacea

Trial Timeline

Jun 21, 2018 → Jun 10, 2019

NCT ID
NCT03564119

About S5G4T-1 + S5G4T-2

S5G4T-1 + S5G4T-2 is a phase 3 stage product being developed by Sol-Gel Technologies for Papulopustular Rosacea. The current trial status is completed. This product is registered under clinical trial identifier NCT03564119. Target conditions include Papulopustular Rosacea.

Hype Score Breakdown

Clinical
27
Activity
18
Company
2
Novelty
9
Community
10

Clinical Trials (2)

NCT IDPhaseStatus
NCT03564119Phase 3Completed
NCT03448939Phase 3Completed

Competing Products

18 competing products in Papulopustular Rosacea

See all competitors
ProductCompanyStageHype Score
Lotilaner Gel, 2.0%Tarsus PharmaceuticalsPhase 2
47
Deucravacitinib + PlaceboBristol Myers SquibbPhase 2
51
Topical Dapsone 5% Gel + oral antibioticsBristol Myers SquibbPhase 3
76
Azelaic acid (Finacea, BAY39-6251) + Metronidazole (Metrogel) + Doxycycline (Oracea)BayerApproved
82
Azelaic Acid foam 15%BayerApproved
82
Azelaic acid + Vehicle foamBayerPhase 2
49
Azelaic acid foam 15% + Vehicle foamBayerPhase 2
49
azelaic acid 15% gel + azelaic acid 15% gelBayerApproved
82
Azelaic Acid Foam + Azelaic Acid GelBayerPhase 1
30
Azelaic acid foam, 15% (BAY39-6251) + Vehicle foamBayerPhase 3
74
DFD-29 + Doxycycline + PlaceboDr. Reddy's LaboratoriesPhase 3
74
DFD-29 + Doxycycline + PlaceboDr. Reddy's LaboratoriesPhase 3
74
Encapsulated Benzoyl Peroxide CreamSol-Gel TechnologiesPhase 1
25
S5G4T-1Sol-Gel TechnologiesPhase 3
69
S5G4T-1 + S5G4T-2Sol-Gel TechnologiesPhase 3
69
FMX103 minocycline foam 1.5% + Vehicle foamVyne TherapeuticsPhase 3
69
FMX103 1.5%Vyne TherapeuticsPhase 3
69
FMX103 minocycline foam 1.5% + Vehicle foamVyne TherapeuticsPhase 3
69

Other Products from Sol-Gel Technologies

S6G5T-3 + S6G5T-8Phase 3
69
5-FU Cream + Efudex® + VehiclePhase 3
69
Patidegib Topical Gel, 2% + Patidegib Topical Gel, VehiclePhase 3
69
S5G4T-1Phase 3
69
S5G4T-1 + S5G4T-2Phase 3
69